Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR4 | P51679 | 20/20 | 0.74 |
| ▸ | CCR5 | P51681 | 1/20 | 0.67 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.67 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10278724 | 0.93 | CCR4 (0.86) | CCR4CCR5FFAR4SLCO1B1 | |
| SCHEMBL14670253 | 0.91 | CCR4 (0.75) | CCR4CCR5FFAR4SLCO1B1 | |
| SCHEMBL14670391 | 0.91 | CCR4 (0.75) | CCR4CCR5FFAR4SLCO1B1 | |
| SCHEMBL14670434 | 0.90 | CCR4 (0.74) | CCR4CCR5FFAR4SLCO1B1 | |
| Trifluoroacetic Acid SCHEMBL3028536 | 0.88 | CCR4 (0.78) | CCR4CCR5FFAR4SLCO1B1 | |
| SCHEMBL14670387 | 0.88 | CCR4 (0.70) | CCR4CCR5FFAR4SLCO1B1 | |
| SCHEMBL14670252 | 0.86 | CCR4 (0.70) | CCR4CCR5FFAR4SLCO1B1 | |
| SCHEMBL357403 | 0.85 | CCR4 (0.91) | CCR4CCR5FFAR4SLCO1B1 | |
| SCHEMBL358085 | 0.85 | CCR4 (1.00) | CCR4CCR5FFAR4SLCO1B1 | |
| SCHEMBL10279002 | 0.85 | CCR4 (0.79) | CCR4CCR5FFAR4SLCO1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130030031-A1 | Novel Compounds | GLAXO GROUP LIMITED (GB) | 2013-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130030031-A1 | Novel Compounds | CYP3A4, CYP3A43, ABCG2 | CCR4 3196/4885CCR5 1719/4885FFAR4 2349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.